# Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice

> **NCT02172495** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 4700 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Tiotropium bromide

## Key facts

- **NCT ID:** NCT02172495
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2003-10
- **Final completion:** —
- **Target enrollment:** 4700 (ACTUAL)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02172495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02172495, "Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02172495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*